WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H1010353
CAS#: 114-07-8
Description: URN14078, or Erythromycin is an inhibitor of protein translation and mammalian mRNA splicing. It inhibits growth of gram negative and gram positiove bacteria.
Hodoodo Cat#: H1010353
Name: Erythromycin
CAS#: 114-07-8
Chemical Formula: C37H67NO13
Exact Mass: 0.00
Molecular Weight: 733.930
Elemental Analysis:
Synonym: URN14078; URN-14078; URN 14078
IUPAC/Chemical Name: (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6- {[(2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}- 14-ethyl-7, 12, 13-trihydroxy-4-{[(2R, 4R, 5S, 6S)- 5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy}- 3, 5, 7, 9, 11
InChi Key: ULGZDMOVFRHVEP-RWJQBGPGSA-N
InChi Code: InChI=1S/C37H67NO13/c1-14-25-37(10, 45)30(41)20(4)27(39)18(2)16-35(8, 44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9, 46-13)31(42)23(7)48-26/h18-26, 28-32, 34, 40-42, 44-45H, 14-17H2, 1-13H3/t18-, 19-, 20+, 21+, 22-
SMILES Code: O=C([C@H](C)[C@@H](O[C@@H]1O[C@@H](C)[C@H](O)[C@](C)(OC)C1)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]3C)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C3=O
Appearance: To be determined
Purity: 98%
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2916.39.79.00
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 733.93 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
